Ledger.Open graph →
SEC Form D · filed September 6, 2016

Solace Therapeutics Inc

Offering
$20.0M
Sold
$13.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
FRAMINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

John G. Mcdonough · Framingham, MADirectorStacy G. Enxing Seng · Framingham, MADirectorKevin G. Connors · Framingham, MADirectorWilliam H. Gruber · Framingham, MAExec · DirectorAli G. Behbahani · Framingham, MADirectorRyan G. Drant · Framingham, MADirectorChris Gandy · Honolulu, HIExec · DirectorMiguel A. Loya · Houston, TXDirectorWilliam R. Ford · Washington, Washington, D.C.DirectorAnthony M. Nee · Washington, Washington, D.C.Exec · DirectorJohn G. Mcdonough · Framingham, MADirectorStacy G. Enxing Seng · Framingham, MADirectorAli G. Behbahani · Framingham, MADirectorRyan G. Drant · Framingham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗